A review of pharmacotherapeutics for prosthetic dentistry: Part II.
BACKGROUND
Successful preoperative and postoperative care often depends on systemically administered drugs. The competent and successful practitioner must therefore have a strong background in basic pharmacology, be knowledgeable of pharmacotherapeutics, and keep abreast of the latest advances in medicinal agents.


OBJECTIVE
The purpose of this article is to review pharmacologic properties of prototype and new drugs that are primarily used to allay anxiety and pain or reduce inflammation and infection. This information should enable clinicians to improve clinical outcomes and make a more knowledgeable assessment and comparison of standard drugs with recently released drugs.
Felpel
L P
LP
University of Texas Health Science Center at San Antonio, USA.
D000701:Analgesics, Opioid; D014151:Anti-Anxiety Agents; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D019551:Dental Disinfectants; D004358:Drug Therapy; D004363:Drug Utilization; D015507:Drugs, Investigational; D006801:Humans; D009125:Muscle Relaxants, Central; D011476:Prosthodontics; D013256:Steroids
D000701:Analgesics, Opioid; D014151:Anti-Anxiety Agents; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D019551:Dental Disinfectants; D015507:Drugs, Investigational; D009125:Muscle Relaxants, Central; D013256:Steroids